Stocks
Novo Nordisk blows its lead
The pharma giant just slashed its full year guidance.
Making sense of market moves
Stay up to date on the latest market news with daily analysis of the investing landscape, served up Brew-style.
By subscribing, you accept our Terms & Privacy Policy.
